Phibro Animal Health | PAHC - Операционный доход





Операционный доход Изменить Дата
Align Technology USD 191.32M 13.27M 2026-06
ANI Pharmaceuticals USD 39.84M 1.13M 2026-06
Aurora Cannabis CAD -10.03M 25.76M 2026-03
Bristol-Myers Squibb USD 299M 3.07B 2026-06
Canopy Growth CAD -27.47M 14.81M 2026-03
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Eli Lilly USD 12.46B 2.68B 2026-06
Henry Schein USD 200M 18M 2026-06
Idexx Laboratories USD 425.57M 62.98M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Merck USD 840M 2.72B 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Pacira USD 9.96M 5.33M 2026-06
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 52.52M 22.97M 2026-06
Supernus Pharmaceuticals USD -21.04M 14.21M 2026-06
Zoetis USD 1.12B 256M 2026-06